Alexza Pharmaceuticals Inc.·4

Jun 22, 3:12 PM ET

Alexza Pharmaceuticals Inc. 4

4 · Alexza Pharmaceuticals Inc. · Filed Jun 22, 2016

Insider Transaction Report

Form 4
Period: 2016-06-21
Transactions
  • Purchase

    Common Stock

    2016-06-21$0.90/sh+19,465,714$17,519,14321,832,649 total(indirect: See Footnotes)
Footnotes (3)
  • [F1]Purchase price paid consisted of $0.90 cash and a contingent value right.
  • [F2]Ownership is held indirectly through a wholly owned subsidiary.
  • [F3]Mr. Ferrer-Salat, as the Chairman and controlling shareholder of Grupo Ferrer Internacional S.A. ("Grupo Ferrer") may be deemed a beneficial owner of the securities held by Grupo Ferrer, but disclaims ownership thereof except to the extent of his pecuniary interest therein.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION